共 50 条
- [43] Hematological and Biochemical Changes among Visceral Leishmaniasis (Kala-Azar) Patients Under Sodium Stibogluconate (SSG) and Ambisome Therapy INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2022, 11 (03): : 26 - 33
- [45] Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
- [47] Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (02):
- [48] RISK ZONE MODELLING AND EARLY WARNING SYSTEM FOR VISCERAL LEISHMANIASIS (KALA-AZAR) DISEASE IN BIHAR, INDIA USING REMOTE SENSING AND GIS XXII ISPRS CONGRESS, TECHNICAL COMMISSION VIII, 2012, 39-B8 : 71 - 75
- [49] Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme. PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (11):